Search Results 6601-6610 of 37780 for oral

  1. A Study to Evaluate Wound Infiltration with Liposomal Bupivacaine in Laparotomy for Gynecological Malignancy - Mayo Clinic

    Prehospitalization narcotic use if weekly average daily oral morphine equivalent of > 20 mg. Chronic pain syndromes such as fibromyalgia. Extensive surgery ...

  2. A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in People With Celiac Disease - Mayo Clinic

    - Previous oral gluten challenge within 12 months. - Selective IgA deficiency. - Diagnosis of Type-1 diabetes. - Active gastrointestinal diseases. - History ...

  3. Radiation therapy for breast cancer - Mayo Clinic

    Find out why doctors use radiation treat breast cancer. Learn what to expect and the side effects of breast cancer radiation, including proton therapy.

  4. Curriculum - Special Coagulation Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    ... oral and written interpretations of test results, possibly including communicating the information to referring physicians. Prepare interpretive reports, or ...

  5. Paul M. Scholten, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral Board ExaminerAmerican Board of Physical Medicine and Rehabilitation. 2021 - 2023. MemberMayo Clinic Wireless biometric monitoring workgroup. 2021. Member ...

  6. Jeff L. Fidler, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral Board ExaminerAmerican Board of Radiology. 2005. Presiding OfficerRadiological Society of North America. 2003 - 2006. SpokespersonSection of ...

  7. Radiation Therapy with or without Temozolomide in Treating Patients with Anaplastic Glioma - Mayo Clinic

    No medical condition that could interfere with oral medication intake (e.g., frequent vomiting or partial bowel obstruction); No other prior malignancies ...

  8. Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer - Mayo Clinic

    ... oral drug intake; No other malignancy within the past 5 years except nonmelanoma skin cancer, carcinoma in situ of the cervix, or ductal carcinoma in situ of ...

  9. A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

    Niraparib is an oral poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2 inhibitor that has shown clinical activity in patients with ovarian cancer.

  10. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

    Topical skin steroid treatment, non-absorbable oral steroid treatment for GI GVHD, and resumption of GVHD prophylaxis agents (e.g., calcineurin inhibitors) are ...